Oncology

The app for iPhone and iPad allows users to use whole body photography to track moles that may develop into melanoma.

A T-cell usually associated with allergies and asthma may be effective in fighting melanoma, according to the results of a recent study.

Researchers at Washington University in St. Louis have developed a genetic test to help predict survival odds for patients with ocular melanoma.

Combination therapy with the BRAF inhibitor vemurafenib and immunotherapy appears to produce improved results in a mouse model.

Compounds extracted from strawberries demonstrated an ability to protect cell culture against DNA damage from ultraviolet radiation, raising the possibility that they could help produce creams to protect against melanoma and other skin cancers.

Several melanoma experts discuss new treatments for the condition, including vemurafenib (Zelboraf) and ipilimumab (Yervoy).

Isaac Brownell, MD, PhD, of Memorial Sloan-Kettering Cancer Center, discusses means of preventing and detecting skin cancers, including basal cell carcinoma, squamous cell carcinoma, and melanoma.

When compared with traditional treatments, biologic therapies for RA were found to not be associated with an increased risk of cancer.

Breakthrough cancer pain-episodes of intense pain experienced by many cancer patients despite around-the-clock treatment with opioids-can be effectively managed with a fentanyl-based oral spray.

Pharmacists can close the information gap for patients with cancer at every stage and provide valuable counseling and support.

Checking for omissions, duplications, dosing errors, compliance, and drug interactions by an inpatient or outpatient pharmacy team can prevent errors and ensure that a patient's medications are accurate and safe.

Pharmacists can and should play a vital role in educating patients about prostate specific antigen testing and current knowledge about prostate cancer.

New antineoplastic agents approved by the FDA for a variety of cancers advance drug therapy as more research spurs the fast pace of change in oncology.

The FDA approved Genetech's Erivedge (vismodegib) capsules for the treatment of adult patients with metastatic basal cell carcinoma(BCC) or with locally advanced BCC that has recurred following surgery, and for patients who are not candidates for radiation.

Staying the course with quality, integrity, and true customer partnerships.

Continuing medical education company PER hosts congress conducted by leading faculty.

Continuing Medical Education Company-PER-Hosts Congress Conducted by Leading Faculty

The United States Food and Drug Administration recently approved Afinitor (everolimus) for use in combination with Aromasin (exemestane) to treat certain postmenopausal women with advanced hormone-receptor positive, HER2-negative breast cancer.

The United States Food and Drug Administration today approved Kyprolis (carfilzomib) to treat patients with multiple myeloma who have received at least 2 prior therapies, including treatment with Velcade (bortezomib) and an immunomodulatory therapy.

An analysis of the top 200 drugs by prescriptions dispensed and total sales reveals key trends in today's pharmaceutical market.

This article-written by Michael Marlan Mohundro, PharmD; and Brice Labruzzo Mohundro, PharmD-highlights the multiple available regimens for patients with relapsed or refractory myelomas as well as new treatments that are currently being investigated in clinical trials.

Specialty Pharmacy Times spoke to Milayna Subar, MD, vice president and national practice leader in oncology for the Oncology Therapeutic Resource Center (TRC) at Express Scripts, to learn more about how access to clinical practice guidelines in oncology can help shape the complex landscape of cancer treatment.